CMD Cantel Medical Corp

DANVILLE, Calif., Sept 21 /PRNewswire-FirstCall/ -- BlueLine Partners today described the special voting procedures being used for its stockholder consent solicitation at Criticare Systems, Inc. (AMEX:CMD). These procedures are required, in part, due to Criticare's failure to comply with BlueLine's request for a list of stockholders. BlueLine has been contacted by many Criticare stockholders asking how to vote their shares in favor of the BlueLine proposals. In a more typical situation, BlueLine would use the stockholder list to mail each shareholder a copy of the consent solicitation. "We cannot do a mailing without the stockholder list," said Scott Shuda, a managing director at BlueLine. "We clearly have strong support among the company's stockholders and therefore believe we can proceed immediately and without doing the normal mailing," Shuda continued. To assist stockholder voting, BlueLine has made the consent solicitation statement and voting instructions available on its website at http://www.bluelinepartners.com/ . Stockholders who hold their shares through a broker or other nominee (i.e., in "street name") and wish to vote for BlueLine's proposals will need to forward the consent to their broker with instructions that their shares be voted in favor of BlueLine's proposals. In most cases, this can be done via email. Anyone requiring assistance should contact Scott Shuda of BlueLine at 925-648-2085. "I've already spoken with representatives of several clearing firms and each is now ready to vote the Criticare shares upon request," said Shuda. "We anticipated that Criticare's management would seek to disregard our requests for the stockholder list and we will do what is necessary to permit Criticare's stockholders to exercise their rights," Shuda continued. Additional Information and Where to Find It BlueLine has filed a consent solicitation statement and other relevant materials with the Securities and Exchange Commission ("SEC"). Before making any voting decision with respect to the proposed solicitation, Criticare stockholders are urged to read the consent solicitation statement and other relevant materials because they will contain important information about the proposed solicitation. The consent solicitation statement and other relevant materials, and any other documents filed by BlueLine with the SEC, may be obtained free of charge at the SEC's website at http://www.sec.gov/ . In addition, copies of the consent statement are available at BlueLine's website at http://www.bluelinepartners.com/ or by mail to BlueLine, 4115 Blackhawk Plaza Circle, Danville, CA 94506, attention: Scott A. Shuda, telephone: 925-648-2085. You may also read and copy any reports, statements and other information filed with the SEC at the SEC public reference room at 100 F Street N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 or visit the SEC's website for further information on its public reference room. Interests of Certain Persons in the Solicitation BlueLine and its officers may be deemed to be participants in the solicitation of consents from Criticare stockholders in favor of the proposed consent solicitation. William M. Moore, an officer of BlueLine, has interests in the transaction that may differ from the interests of Criticare stockholders generally, inasmuch as he will be elected to the Criticare board of directors if the consent solicitation is successful. These interests are described in the consent solicitation statement. DATASOURCE: BlueLine Partners, LLC CONTACT: Scott Shuda of BlueLine Partners, LLC, +1-650-400-0981, or Web site: http://www.bluelinepartners.com/

Copyright